ZA200710338B - Oxydiazole derivatives as DGAT inhibitors - Google Patents

Oxydiazole derivatives as DGAT inhibitors

Info

Publication number
ZA200710338B
ZA200710338B ZA200710338A ZA200710338A ZA200710338B ZA 200710338 B ZA200710338 B ZA 200710338B ZA 200710338 A ZA200710338 A ZA 200710338A ZA 200710338 A ZA200710338 A ZA 200710338A ZA 200710338 B ZA200710338 B ZA 200710338B
Authority
ZA
South Africa
Prior art keywords
dgat inhibitors
oxydiazole derivatives
oxydiazole
derivatives
dgat
Prior art date
Application number
ZA200710338A
Inventor
Butlin Roger John
Mccoull William
Green Clive Philip
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200710338B publication Critical patent/ZA200710338B/en

Links

ZA200710338A 2005-06-11 2007-11-28 Oxydiazole derivatives as DGAT inhibitors ZA200710338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0511851A GB0511851D0 (en) 2005-06-11 2005-06-11 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA200710338B true ZA200710338B (en) 2008-11-26

Family

ID=34855346

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710338A ZA200710338B (en) 2005-06-11 2007-11-28 Oxydiazole derivatives as DGAT inhibitors

Country Status (3)

Country Link
CN (1) CN101243058A (en)
GB (1) GB0511851D0 (en)
ZA (1) ZA200710338B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR075177A1 (en) * 2009-01-28 2011-03-16 Sanofi Aventis DERIVATIVES OF TIADIAZOLS AND OXADIAZOLS, METHOD OF PREPARATION, SYNTHESIS INTERMEDIARIES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN AND USE THEMSELVES IN THE TREATMENT OF METABOLIC DISORDERS, SUCH AS OBESITY AND DIABETES, BETWEEN.
KR20130094211A (en) * 2010-04-27 2013-08-23 다케다 야쿠힌 고교 가부시키가이샤 Bicyclic compound derivatives and their use as acc inhibitors

Also Published As

Publication number Publication date
CN101243058A (en) 2008-08-13
GB0511851D0 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
IL187451A0 (en) Oxadiazole derivatives as dgat inhibitors
TWI370127B (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
PT2402319T (en) Dgat inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
ZA200700181B (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
IL183279A0 (en) Oxadiazole derivatives as dgat inhibitors
ZA200606683B (en) Pyrazolotriazines as kinase inhibitors
IL192603A0 (en) Thieno-pyridine derivatives as mek inhibitors
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
EP2046333A4 (en) Thiozolidinedione derivatives as p13 kinase inhibitors
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
ZA200800672B (en) Introcatechol derivatives as COMT inhibitors
ZA200705024B (en) Oxadiazole derivatives as DGAT inhibitors
ZA200808598B (en) Pyrrolopyrimidine derivatives used as HSP90 inhibitors
ZA200710338B (en) Oxydiazole derivatives as DGAT inhibitors
ZA200706212B (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
EP1940411A4 (en) Macroheterocylic compounds as kinase inhibitors